Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 984 entries
View as:

A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT02993926 Org: User:
Start: 06/24/17 End: 09/30/18 Due: 09/30/19

A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis

Phase: N/A Priority: Normal
NCT ID: NCT04799496 Org: User:
Start: 06/10/20 End: 01/14/26 Due: 01/14/27

A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03497429 Org: User:
Start: 04/05/18 End: 02/10/20 Due: 02/10/21

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland

Phase: N/A Priority: Normal
NCT ID: NCT04989907 Org: User:
Start: 09/08/21 End: 05/17/24 Due: 05/17/25

Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01496430 Org: User:
Start: 01/31/12 End: 05/31/13 Due: 05/31/14

A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05163314 Org: User:
Start: 03/04/22 End: 05/22/26 Due: 05/22/27

A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Disease

Phase: N/A Priority: Normal
NCT ID: NCT02512068 Org: User:
Start: 08/07/15 End: 04/24/18 Due: 04/24/19

A Study of Velaglucerase Alfa (VPRIV) Given as Standard Patient Care in Young Children With Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT04721366 Org: User:
Start: 01/08/21 End: 04/17/23 Due: 04/17/24

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT06764615 Org: User:
Start: 05/28/25 End: 12/30/29 Due: 12/30/30

A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03586973 Org: User:
Start: 08/06/18 End: 06/29/21 Due: 06/29/22

A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

Phase: N/A Priority: Normal
NCT ID: NCT04206605 Org: User:
Start: 05/04/20 End: 10/20/22 Due: 10/20/23

A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Phase: N/A Priority: Normal
NCT ID: NCT05020015 Org: User:
Start: 11/12/21 End: 06/20/30 Due: 06/20/31

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

Phase: N/A Priority: Normal
NCT ID: NCT02467270 Org: User:
Start: 06/30/15 End: 04/23/25 Due: 04/23/26

Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04804813 Org: User:
Start: 03/29/21 End: 07/25/24 Due: 07/25/25

A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance

Phase: N/A Priority: Normal
NCT ID: NCT01953081 Org: User:
Start: 01/31/14 End: 10/31/14 Due: 10/31/15

Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Phase: N/A Priority: Normal
NCT ID: NCT00251745 Org: User:
Start: 12/31/05 End: 05/31/06 Due: 05/31/07

Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01355081 Org: User:
Start: 05/31/11 End: 12/31/12 Due: 12/31/13

A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated With Anaplastic Lymphoma Kinase (ALK) Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT03546894 Org: User:
Start: 07/23/18 End: 02/13/23 Due: 02/13/24

A Study of Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT05098054 Org: User:
Start: 10/29/21 End: 06/07/22 Due: 06/07/23

Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)

Phase: N/A Priority: Normal
NCT ID: NCT00336219 Org: User:
Start: 08/31/06 End: 04/30/07 Due: 04/30/08

Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03042325 Org: User:
Start: 07/30/17 End: 01/15/18 Due: 01/15/19

Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c

Phase: N/A Priority: Normal
NCT ID: NCT00817739 Org: User:
Start: 12/31/96 End: 12/31/08 Due: 12/31/09

Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03706456 Org: User:
Start: 03/06/19 End: 02/10/23 Due: 02/10/24

Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT00755846 Org: User:
Start: 03/31/05 End: 10/31/05 Due: 10/31/06

A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT05626088 Org: User:
Start: 04/10/23 End: 08/30/25 Due: 08/30/26